Roivant Sciences (ROIV) Change in Account Payables (2020 - 2025)

Roivant Sciences has reported Change in Account Payables for 6 years, with the latest figure at -$12.7 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Account Payables rose 29.25% year-over-year to -$12.7 million; the trailing twelve-month figure through Dec 2025 stood at -$39.5 million (down 15.25% YoY), and the FY2026 full-year result was $3.4 million, up 118.81% from the prior year.
• Change in Account Payables for Q4 2025 stood at -$12.7 million, down from $3.0 million in the prior quarter.
• The five-year high for Change in Account Payables was $62.9 million in Q3 2021, with the low at -$25.3 million in Q2 2024.
• Historically, Change in Account Payables has averaged $2.4 million across 5 years, with a median of $1.8 million in 2023.
• The largest YoY upside for Change in Account Payables was 501.0% in 2024 against a maximum downside of 1101.84% in 2024.
• Roivant Sciences' Change in Account Payables stood at $3.7 million in 2021, then soared by 278.28% to $14.0 million in 2022, then tumbled by 87.14% to $1.8 million in 2023, then slumped by 1101.84% to -$18.0 million in 2024, then increased by 29.25% to -$12.7 million in 2025.
• The last three Change in Account Payables figures came in at -$12.7 million (Q4 2025), $3.0 million (Q3 2025), and -$11.7 million (Q2 2025), per Business Quant data.